title: Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway.
abstract: Following successful chemotherapy in canine visceral leishmaniasis, monocyte-derived macrophages can induce antileishmanial activity via a gamma interferon-dependent mechanism in the presence of autologous lymphocytes. The killing of leishmania correlated with the induction of the NO synthase pathway, because it correlated with the generation of nitrogen derivative production and was abrogated in the presence of NG-monomethyl-L-arginine, a competitive inhibitor of the NO synthase pathway. The level of L-citrulline in serum, which was produced after activation of the NO synthase pathway, was markedly enhanced in dogs receiving successful chemotherapy. Taken together, these data indicate that following successful chemotherapy of visceral leishmaniasis, leishmania parasites are killed by macrophages activated by gamma interferon-producing lymphocytes via an NO-dependent mechanism.
authors.affiliation: Laboratoire de Parasitologie Experimentale, Faculté de Médecine Pitié Salpétrière, Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: Vouldoukis
authors.forename: J C
authors.initials: JC
authors.lastname: Drapier
authors.forename: A K
authors.initials: AK
authors.lastname: Nüssler
authors.forename: Y
authors.initials: Y
authors.lastname: Tselentis
authors.forename: O A
authors.initials: OA
authors.lastname: Da Silva
authors.forename: M
authors.initials: M
authors.lastname: Gentilini
authors.forename: D M
authors.initials: DM
authors.lastname: Mossalayi
authors.forename: L
authors.initials: L
authors.lastname: Monjour
authors.forename: B
authors.initials: B
authors.lastname: Dugas
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology; D004283:Dog Diseases / Q000188:drug therapy* / Q000276:immunology / Q000469:parasitology; D004285:Dogs; D007371:Interferon-gamma / Q000494:pharmacology; D018314:Leishmania infantum / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000276:immunology / Q000662:veterinary*; D008264:Macrophages / Q000187:drug effects / Q000276:immunology* / Q000469:parasitology; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000502:physiology
chemical_list: D000981:Antiprotozoal Agents; D009569:Nitric Oxide; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase